RecallCheckr

Serious recall: Injury is possible or has been reported. Take action promptly.

Noven Pharmaceuticals Inc 2023-03-29 Health serious FDA
Health · FDA · Recall #FDA-D-0473-2023

Daytrana (methylphenidate transdermal system) CII, 30 mg, 30-count carton, Rx only,… Recall

Issued March 29, 2023 · Noven Pharmaceuticals Inc

In March 2023, Noven Pharmaceuticals Inc recalled the Daytrana (methylphenidate transdermal system) CII, 30 mg, 30-count carton, Rx only,…, a serious health recall reported by the FDA.

Compiled by Maya Ellison, RecallCheckr

What this means for you

Defective Delivery System: Out of specification for shear.

What you should do

  1. 1 Stop using Daytrana (methylphenidate transdermal system) CII, 30 mg, 30-count carton, Rx only,… right away.
  2. 2 Set it aside where it won't be used by mistake.
  3. 3 Contact Noven Pharmaceuticals Inc to arrange your voluntary. See the official notice below for contact details.
  4. 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):

Recall details

Brand
Noven Pharmaceuticals Inc
Category
Health
Recall date
March 29, 2023
Units affected
Not reported
Sold at
US Nationwide
Recall number
FDA-D-0473-2023
Made in
United States
Issuing agency
FDA

In context

  • Noven Pharmaceuticals Inc has 3 recalls in our database.
  • We're tracking 3,576 Health recalls in our database.
  • This is the 903rd Health recall we've logged in 2023.
Read the official FDA notice

Related recalls